Correlation Between Finch Therapeutics and Climb Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Finch Therapeutics and Climb Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Finch Therapeutics and Climb Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Finch Therapeutics Group and Climb Bio, you can compare the effects of market volatilities on Finch Therapeutics and Climb Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Finch Therapeutics with a short position of Climb Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Finch Therapeutics and Climb Bio.

Diversification Opportunities for Finch Therapeutics and Climb Bio

0.73
  Correlation Coefficient

Poor diversification

The 3 months correlation between Finch and Climb is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Finch Therapeutics Group and Climb Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Climb Bio and Finch Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Finch Therapeutics Group are associated (or correlated) with Climb Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Climb Bio has no effect on the direction of Finch Therapeutics i.e., Finch Therapeutics and Climb Bio go up and down completely randomly.

Pair Corralation between Finch Therapeutics and Climb Bio

If you would invest  851.00  in Finch Therapeutics Group on October 1, 2024 and sell it today you would earn a total of  0.00  from holding Finch Therapeutics Group or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy1.59%
ValuesDaily Returns

Finch Therapeutics Group  vs.  Climb Bio

 Performance 
       Timeline  
Finch Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Finch Therapeutics Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong fundamental indicators, Finch Therapeutics is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.
Climb Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Climb Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Finch Therapeutics and Climb Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Finch Therapeutics and Climb Bio

The main advantage of trading using opposite Finch Therapeutics and Climb Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Finch Therapeutics position performs unexpectedly, Climb Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Climb Bio will offset losses from the drop in Climb Bio's long position.
The idea behind Finch Therapeutics Group and Climb Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios